Skip to content
The Nexus
BUSINESSJun 16 · 01:40 UTCBLOOMBERG

Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker

Biocon's Mazumdar Shaw stated the company is on track to become a leading insulin manufacturer. The firm aims to strengthen its position in the insulin market.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
BioconorganizationMazumdar Shawpersoninsulintopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting